96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Electrophoresis standards, methods and kits
#5402Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents
#5403Orally administered small peptides synergize statin activity
#5404PRAME peptide analogues
#5405Melanoma antigen peptide analogues
#5406Cell-permeable peptide inhibitors of the JNK signal transduction pathway
#5407Novel peptide, novel adsorbent, adsorption unit and adsorption method
#5408Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation
#5409Kinase and phosphatase assays
#5410Methods for selective targeting
#5411HLA binding motifs and peptides and their uses
#5412Treatment of ischemic events
#5413Template-fixed peptidomimetics with antimicrobial activity
#5414Methods of identifying optimal variants of peptide epitopes
#5415Peptide-based conditioners and colorants for hair, skin, and nails
#5416Modified transferrin fusion proteins
#5417PSMA peptide analogues
#5418Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#5419Mass tags for quantitative analyses
#5420Peptide-based conditioners and colorants for hair, skin, and nails
#5421Peptide dependent upregulation of telomerase expression
#5422Modified cytokines for use in cancer therapy
#5423Peptides for selectively and specifically binding Bacillus anthracis spores and use thereof in landscape phages
#5424Peptide antagonists for inhibiting heat shock protein (Hsp 16.3) of
#5425HLA-A24 binding cancer antigen peptide derived from livin
#5426antigens
#5427Oligopeptide antagonist of interleukin-6
#5428Antimicrobial peptides and utilization of the same
#5429Antimicrobial agents
#5430Novel enterokinase cleavage sequences
#5431Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
#5432Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock
#5433Specificity exchangers that redirect antibodies to a pathogen
#5434Compositions and methods for WT1 specific immunotherapy
#5435Coloring compositions with peptide-based dispersants and binders
#5436Conjugates useful in the treatment of prostate cancer
#5437Orthogonally protected bifunctional amino acid
#5438Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
#5439Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
#5440Paralytic peptide for use in neuromuscular therapy
#5441Peptidic conjugates for alopecia prevention and treatment
#5442Stationary phases and a purification process using the stationary phases
#5443Methionine aminopeptidase-2 inhibitors and methods of use thereof
#5444Peptide Conjugates and Fluorescence Detection Methods for Intarcellular Caspase Assay
#5445Treatment of dry eye
#5446Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor
#5447Method of treating interferon non-responders using HCV protease inhibitor
#5448Beta-sheet mimetics and methods relating to the use thereof
#5449Conformationally stabilized cell adhesion peptides
#5450Phex substrates and methods using same
#5451Chimeric polypeptides and their use
#5452METHODS AND COMPOUNDS FOR PREVENTION AND TREATMENT OF ELEVATED INTRAOCULAR PRESSURE AND RELATED CONDITIONS
#5453Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions
#5454Biologically active peptides
#5455Antimicrobial peptides
#5456Potentialization of the activation of high molecular weight prodrugs
#5457Methods of treatment using novel LHRH antagonists having improved solubility properties
#5458Polymyxin B analogs for LPS detoxification
#5459KAPREKY peptidomimetics and analogues thereof
#5460Metod of modulation of interaction between receptor and ligand
#5461Influenza virus inhibiting peptides
#5462Peptides modulating caspase activation
#5463Compositions and methods for fusion protein separation
#5464β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
#5465Agonist polypeptide of receptor for ZOT and zonulin
#5466Pharmaceutical composition and method for inhibiting gastrointestinal inflammation
#5467Albumin fusion proteins
#5468Biological control of nanoparticle nucleation, shape and crystal phase
#5469Tumor targeting agents and uses thereof
#5470Dolastatin 15 derivatives
#5471Acylated nonadepsipeptides containing pyridyl alanine residues
#5472Compounds for targeting endothelial cells, compositions containing the same and methods for their use
#5473Tumor targeting agents and uses thereof
#5474Single domain TDF-related compounds and analogs thereof
#5475Purified polypeptides from
#5476Methods and compositions for the treatment of gastrointestinal disorders
#5477Materials and methods for regulating blood flow
#5478Peptide anti-tumor agent
#5479Compounds for targeting endothelial cells, compositions containing the same and methods for their use
#5480Pseudomycin production by pseudomonas syringae
#5481Icam-4 binding sites
#5482Peptide conjugates and fluorescence detection methods for intracellular caspase assay
#5483Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
#5484Volatilizable solid phase supports for compound synthesis
#5485Peptidomimetic polymers for antifouling surfaces
#5486Peptides promoting cell adherence, growth and secretion
#5487Modified therapeutic agents
#5488Intermediate for preparing glycopeptide derivatives
#5489Selectin targeting bioconjugates
#5490Protein tyrosine phosphatase inhibitors
#5491MN gene and protein
#5492Peptides directed for diagnosis and treatment of amyloid-associated disease
#5493Beta-secretase inhibitors and methods of use
#5494Biologically active peptides comprising Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (IVTNTT)
#5495Secondary binding site of dipeptidyl peptidase IV (DP IV)
#5496Cell death-inducing fused gene acting specifically on cancer and gene product thereof
#5497Neuroprotective iron chelators and pharmaceutical compositions comprising them
#5498Template-fixed peptidomimetics as medicaments against HIV and cancer
#5499Antitumoral compounds
#5500Methods for modulating neuronal responses
#5501Compositions and methods for increasing drug efficiency
#5502Method of stimulating growth and resistance to diseases of aquatic organisms
#5503Assay method
#5504Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
#5505Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#5506Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors
#5507Antimicrobial hexapeptides
#5508Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same
#5509Peptide-enhanced transfections
#5510Synthetic mimics of mammalian cell surface receptors: method and compositions
#5511Serum albumin binding peptides for tumor targeting
#5512Endothelial cell specifically binding peptides
#5513Protein scaffolds and uses thereof
#5514Cosmetic composition comprising a and a lipopeptide
#5515Peptide-based body surface coloring reagents
#5516Peptide-chelate conjugates
#5517Activation of peptide prodrugs by hK2
#5518Dimerized peptide
#5519Compounds binding to p-selectin
#5520Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides
#5521Methods for proteomic profiling using non-natural amino acids
#5522Method for isolating hepatitis C virus peptides
#5523Immunological markers
#5524KDR peptides and vaccines comprising the same
#5525Cell cycle targets and peptides
#5526Zinc finger binding domains for nucleotide sequence ANN
#5527Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#5528Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin Freceptor
#5529Surfactant peptide nanostructures, and uses thereof
#5530Very large scale immobilized polymer synthesis
#5531Anti-angiogenic compounds
#5532Peptides, antibodies thereto, and their use in treatment of central nervous system, damage
#5533Intracellular delivery of biological effectors
#5534Mucin hypersecretion inhibitors and methods of use
#5535Hepta-, octa-and nonapeptides having antiangiogenic activity
#5536Albumin fusion proteins
#5537Polypeptide array synthesis
#5538Peptides for inhibiting retroviruses
#5539Binding molecules for human factor VIII and factor VIII-like proteins
#5540Receptor-mediated uptake of peptides that bind the human transferrin receptor
#5541Imaging agents
#5542Thrombopoietic compounds
#5543Protein and its use in diagnosing Alzheimer's disease
#5544Compounds and methods for modulating cell adhesion
#5545Activation of peptide prodrugs by hK2
#5546Control of lactation
#5547Intracellular delivery of biological effectors
#5548Restoring vascular function
#5549Anti-angiogenic peptides and methods of use thereof
#5550Skin or hair binding peptides
#5551Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
#5552Biologically active peptide conjugates
#5553Non-T cell binding peptides and their uses
#5554Insulin conjugates and methods of use thereof
#5555Leukocyte stimulating peptides
#5556Novel use of lipopeptide preparations
#5557Cell adhesion inhibitors
#5558Induction of the mitochondrial permeability transition
#5559Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof
#5560Amino acid and peptide conjugates of amiloride and methods of use thereof
#5561Peptides that selectively home to heart vasculature and related conjugates and methods
#5562Peptide nucleic acids
#5563Prostate-specific antigen probes for optical imaging
#5564Purification of immunoglobulins using affinity chromatography and peptide ligands
#5565Compounds for targeting endothelial cells, compositions containing the same and methods for their use
#5566Composition and method for self-assembly and mineralization of peptide amphiphiles
#5567Homing peptides to receptors of heart vasculature
#5568Conjugates useful in the treatment of prostate cancer
#5569Peptidic sulfonamides
#5570Oligopeptides, composition and use thereof as elicitors of the natural defences of plants
#5571Biomolecule transduction motif Mph-1-BTM and the use thereof
#5572Pyrrolidine derivatives for use in treating heaptitis c virus infection
#5573Ultra-high specificity fluorescent labeling
#5574Reagents and procedures for multi-label high-specificity labeling
#5575Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
#5576Phenolic binding peptides
#5577BLy antagonists and uses thereof
#5578Glycogen synthase kinase-3 inhibitors
#5579Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
#5580Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
#5581Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
#5582Antimicrobial peptides with reduced hemolysis and methods of their use
#5583Method for inhibiting "melanoma inhibitory activity" mia
#5584Specific binding agents of human angiopoietin-2
#5585Antimicrobial peptides and use thereof
#5586Method of reducing the effects of Abeta and compositions therefore
#5587Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions
#5588Fluorogenic enzyme assay methods, kits and compositions using charge-balancers
#5589Molecular modification assays
#5590Methods and compositions for treating cellular proliferative diseases
#5591Modified cytokines for use in cancer therapy
#5592Methods for preventing and treating Alzheimer's disease
#5593Structured peptide scaffold for displaying turn libraries on phage
#5594Synthesis and self-assembly of ABC triblock bola peptide amphiphiles
#5595Antimicrobials against pathogenic bacteria and method for screening them
#5596Peptidic thrombin inhibitors
#5597Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing, and treating HIV
#5598Ligands to radiation-induced molecules
#5599Cell nucleus-entering compositions
#5600Vector for improved in vivo production of proteins
#5601Stabilized bioactive peptides and methods of identification, synthesis, and use
#5602Composition and method for increasing apoptosis in cancer cells
#5603Process for producing a recombinant protein in a mycobacterium host plasmid pJAM2
#5604Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
#5605Specificity exchangers that redirect antibodies to a pathogen
#5606Interleukin-1 receptor antagonists, compositions, and methods of treatment
#5607NY-ESO-1 peptide analogs
#5608Hybrid polypeptides with selectable properties
#5609Conductive peptide nanofiber and method of manufacture of the same
#5610Smart pro-drugs of serine protease inhibitors
#5611Peptides that bind to the heparin binding domian of vegf and vegfr-2
#5612Peptides for use in culture media
#5613Purification of recombinant proteins fused to multiple epitopes
#5614Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
#5615Process for partitioning of proteins
#5616CaMKII/calcium channel binding-related compositions and methods
#5617Method for obtaining anti-idiotype antibodies
#5618Antimicrobial agents
#5619Anti-Fc-gamma RIIB receptor antibody and uses therefor
#5620Synthetic glyco-lipo-peptides as vaccines
#5621Glycogen synthase kinase-3 inhibitors
#5622Peptide-modified polyurethane compositions and associated methods
#5623Selection of peptide ligands specific for baculovirus DNA-binding protein from the FliTrx™ random peptide display library
#5624SSX-2 peptide analogs
#5625Low molecular weight peptidomimetic growth hormone secretagogues
#5626Modified interferon alpha with reduced immunogenicity
#5627Colon tumor specific binding peptides
#5628Epitope analogs
#5629Antimicrobial polypeptide and utilization thereof
#5630Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
#5631Transglutaminase inhibitors and methods of use thereof
#5632The Sperm Binding Ligand HIPRTY and Its Involvement in Embryo Cleavage
#5633Site-specific labelling of proteins using acridone and quinacridone lifetime dyes
#5634CEA binding agents and compositions to reverse CEA-mediated tumorigenic effects on human cancer cells, restore sensitivity to drug induced apoptosis and uses thereof
#5635Method of eliminating phosphate group of peptide and method of analyzing peptide
#5636Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
#5637Use of nucleic acid analogues in diagnostics and analytical procedures
#5638Peptide-based multimeric targeted contrast agents
#5639Processes for preparing eptifibatide
#5640Drug therapy for Celiac Sprue
#5641Reagents and methods for smooth muscle therapies
#5642Synthetic peptides, conjugation reagents and methods
#5643Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
#5644Production and use of novel peptide-based agents with bispecific antibodies
#5645Radiolabeled annexins
#5646Microwave-assisted peptide synthesis
#5647Microwave-assisted peptide synthesis
#5648Microwave-assisted peptide synthesis
#5649Hybrid molecules QA, wherein Q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent
#5650Covalent tethering of functional groups to proteins and substrates therefor
#5651Antibodies and cyclic peptides which bind CEA (carcinoembryonic antigens) and their use as cancer therapeutics
#5652Synthetic peptides that bind to the hepatitis B virus core and E antigens
#5653Compositions and methods for counteracting effects of reactive oxygen species and free radicals
#5654EphA2 T-cell epitopes and uses therefor
#5655Conopeptides and methods of use
#5656Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
#5657Inhibitors of IAP
#5658Pharmaceutical compositions for prevention of overdose or abuse
#5659Modulators of β-amyloid peptide aggregation comprising D-amino acids
#5660Peptide purification
#5661Bone delivery conjugates and method of using same to target proteins to bone
#5662Cyclic peptides for treatment for cachexia
#5663Antigenic gp 100 compounds for therapy and diagnosis and methods of using same
#5664Cyclic peptides for treatment of cachexia
#5665Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
#5666Antineoplastic peptides
#5667Method and peptide for regulating cellular activity
#5668T-cell death-inducing epitopes
#5669Peptides and methods for cell death regulation
#5670Pharmaceuticals for the imaging of angiogenic disorders
#5671Method of making metallopeptides
#5672Omi PDZ modulators
#5673Attenuation of metapneumovirus
#5674Connective tissue stimulating peptides
#5675Peptide amidation process
#5676Isolating biological modulators from biodiverse gene fragment libraries
#5677Therapeutic compositions and methods for treating diseases that involve angiogenesis
#5678Peptide capable of binding to nanographite structures
#5679Immunoaffinity chromatography using epitope tags to polyol-responsive monoclonal antibodies
#5680Retrocyclins: antiviral and antimicrobial peptides
#5681Kinase mimic catalysts for asymmetric synthesis of phosphorylated inositols and cycloalkanols
#5682IL-16 antagonists
#5683Peptides of CaV2.2 that inhibit pain
#5684Process for the synthesis of peptides amides by side-chain attachment to a solid phase
#5685Method for screening biomolecule activity regulator
#5686Modified cytokines for use in cancer therapy
#5687Binding moieties for fibrin
#5688Myosin light chain kinase inhibitors and methods of use
#5689Synthetic transfer complex and method for transferring nucleic acids
#5690Immunoglobulin chimeric monomer-dimer hybrids
#5691Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
#5692Peptide inhibitors of HIV
#5693Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#5694Chromatin remodeling protein as a marker expressed by stromal progenitor cells
#5695KDR and VEGF/KDR binding peptides
#5696Reversible modification of membrane interaction
#5697PNA conjugate for treating chronic myeloid leukemia (CML)
#5698Fluorogenic kinase assays and substrates
#5699Methods and compositions for impairing multiplication of HIV-1
#5700Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs